Deep Health AI India Ltd

AI
Deep Health AI Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Deep Health AI India Ltd

₹ 1.64 0.61%
09 Oct - close price
deephealthindia.io BSE: 539559
About

Incorporated in 1993, Deep Health AI India Ltd is in the business of pharmaceuticals and AI-based healthcare products.[1]

Key Points

Business Overview:[1][2]
DHAIL was engaged in the business Rough
& Polished Diamonds, and trading of diamond studded jewellery & Gold Jewellery.
In FY23, the company also started the business of providing consultancy service to Pharma Industry and marketing of pharmaceutical products. Currently, it is also expanding it
to AI based healthcare products in India

Website BSE
  • Market Cap ₹ 23.6 Cr.
  • Current Price ₹ 1.64
  • High / Low ₹ 10.3 / 1.50
  • Stock P/E 4.64
  • Book Value ₹ 3.58
  • Dividend Yield 6.10 %
  • ROCE 11.4 %
  • ROE 8.99 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 0.46 times its book value
  • Stock is providing a good dividend yield of 6.10%.

Cons

  • Promoter holding is low: 0.03%
  • Company has a low return on equity of 6.03% over last 3 years.
  • Company has high debtors of 251 days.
  • Working capital days have increased from 121 days to 405 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Consumer Discretionary Consumer Durables Consumer Durables Gems, Jewellery And Watches

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
0.30 0.89 0.86 1.70 0.51 0.30 0.00 0.45 0.15 3.35 0.50 0.25 0.45
0.22 1.47 0.77 2.03 0.29 0.17 0.15 0.21 0.20 0.12 0.39 0.19 2.51
Operating Profit 0.08 -0.58 0.09 -0.33 0.22 0.13 -0.15 0.24 -0.05 3.23 0.11 0.06 -2.06
OPM % 26.67% -65.17% 10.47% -19.41% 43.14% 43.33% 53.33% -33.33% 96.42% 22.00% 24.00% -457.78%
0.27 0.26 0.55 0.54 0.19 0.09 0.22 0.25 0.19 0.16 3.71 -5.60 0.17
Interest 0.12 0.03 0.05 0.21 0.03 0.02 0.01 0.03 0.01 0.01 0.01 0.01 0.01
Depreciation 0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax 0.23 -0.35 0.58 -0.01 0.38 0.20 0.06 0.46 0.13 3.38 3.81 -5.55 -1.90
Tax % 26.09% 0.00% 10.34% 1,000.00% 26.32% 25.00% 83.33% 8.70% 23.08% 25.15% 16.01% -18.56% 0.00%
0.17 -0.35 0.52 -0.11 0.29 0.15 0.01 0.41 0.09 2.53 3.20 -4.52 -1.90
EPS in Rs 0.02 -0.04 0.05 -0.01 0.03 0.02 0.00 0.04 0.01 0.18 0.22 -0.31 -0.13
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
3.13 1.17 3.29 1.66 1.25 0.81 0.51 1.39 7.67 2.56 1.25 4.25 4.55
3.04 1.40 3.38 1.94 1.54 1.11 0.74 1.38 6.03 2.80 0.80 0.92 3.21
Operating Profit 0.09 -0.23 -0.09 -0.28 -0.29 -0.30 -0.23 0.01 1.64 -0.24 0.45 3.33 1.34
OPM % 2.88% -19.66% -2.74% -16.87% -23.20% -37.04% -45.10% 0.72% 21.38% -9.38% 36.00% 78.35% 29.45%
0.16 0.19 0.22 0.28 0.28 0.29 0.26 0.26 0.23 1.09 0.75 -1.53 -1.56
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 0.26 0.09 0.03 0.04
Depreciation 0.03 0.05 0.04 0.02 0.02 0.02 0.02 0.00 0.01 0.01 0.01 0.01 0.00
Profit before tax 0.22 -0.09 0.09 -0.02 -0.03 -0.03 0.01 0.27 1.73 0.58 1.10 1.76 -0.26
Tax % 31.82% -11.11% 22.22% 0.00% 0.00% 0.00% 500.00% 25.93% 27.75% 27.59% 21.82% 26.14%
0.15 -0.07 0.07 -0.02 -0.02 -0.03 -0.05 0.20 1.26 0.42 0.86 1.30 -0.69
EPS in Rs 0.02 -0.01 0.01 -0.00 -0.00 -0.00 -0.01 0.02 0.13 0.04 0.09 0.09 -0.04
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 110.92%
Compounded Sales Growth
10 Years: 14%
5 Years: 53%
3 Years: -18%
TTM: 406%
Compounded Profit Growth
10 Years: 48%
5 Years: 143%
3 Years: 38%
TTM: 671%
Stock Price CAGR
10 Years: 6%
5 Years: 8%
3 Years: -33%
1 Year: -72%
Return on Equity
10 Years: 5%
5 Years: 6%
3 Years: 6%
Last Year: 9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 3.20 3.20 3.20 3.20 3.20 3.20 3.20 3.20 4.81 4.81 4.81 14.42
Reserves 4.43 4.36 4.44 4.45 4.38 4.30 4.28 4.48 9.92 15.62 17.54 37.12
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.86 1.66 0.61 0.37
0.15 0.22 0.24 0.07 0.07 0.30 0.11 0.06 1.29 0.98 0.99 0.34
Total Liabilities 7.78 7.78 7.88 7.72 7.65 7.80 7.59 7.74 19.88 23.07 23.95 52.25
0.40 0.36 0.32 0.30 0.29 0.27 0.00 0.00 4.47 4.46 4.45 4.44
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.13 0.10 0.16 0.17 0.25 0.19 0.26 0.20 0.00 3.56 5.59 28.56
7.25 7.32 7.40 7.25 7.11 7.34 7.33 7.54 15.41 15.05 13.91 19.25
Total Assets 7.78 7.78 7.88 7.72 7.65 7.80 7.59 7.74 19.88 23.07 23.95 52.25

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-0.39 -0.19 0.08 -0.69 -0.25 -0.28 -0.15 0.55 3.23 -5.41 1.34 -3.64
0.06 0.23 0.18 0.29 0.13 0.30 0.27 0.29 -4.03 -2.25 -0.23 -29.20
0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.79 5.01 -1.15 37.87
Net Cash Flow 0.17 0.04 0.26 -0.40 -0.12 0.02 0.12 0.84 4.99 -2.65 -0.04 5.03
Free Cash Flow -0.39 -0.19 0.08 -0.69 -0.26 -0.28 -0.08 0.55 -1.25 -5.41 1.34 -3.64
CFO/OP -433% 65% -156% 246% 86% 93% 65% 5,700% 203% 2,254% 336% -61%

Ratios

Standalone / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 213.40 455.47 142.01 167.11 169.36 202.78 293.43 118.17 127.54 208.16 148.92 250.78
Inventory Days 446.78 1,621.71 400.81 877.67 1,120.30 1,942.92 3,432.97 1,207.61 86.55 264.73 1,241.00
Days Payable 0.00 69.30 19.28 0.00 0.00 0.00 0.00 11.65 84.11 236.65 1,630.33
Cash Conversion Cycle 660.19 2,007.88 523.53 1,044.78 1,289.66 2,145.70 3,726.40 1,314.12 129.99 236.24 -240.41 250.78
Working Capital Days 798.80 2,130.73 735.55 886.11 1,138.80 1,662.78 2,784.02 947.95 -60.91 -27.09 -14.60 405.36
ROCE % 3.01% -1.18% 1.18% -0.26% -0.39% -0.40% -0.40% 3.30% 14.24% 4.03% 5.28% 11.41%

Insights

In beta
Mar 2019 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Pharmaceutical Segment Revenue Share
% of Total Revenue

Log in to view insights

Please log in to see hidden values.

Login
Number of Permanent Employees
Count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.03% 0.03% 0.03%
1.04% 1.04% 1.04% 1.04% 1.04% 1.04% 1.04% 1.04% 1.04% 0.35% 0.35% 0.35%
98.87% 98.88% 98.88% 98.87% 98.87% 98.88% 98.87% 98.87% 98.88% 99.63% 99.63% 99.62%
No. of Shareholders 29,04428,15727,51426,50863,03266,38663,30462,52760,44477,63294,37991,618

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue